Try our Advanced Search for more refined results
January 20, 2012
Spectrum Pharmaceuticals, Inc. et al v. Sandoz Inc.
Case Number:
2:12-cv-00111
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 23, 2012
Sandoz Targeted Over Generic Cancer Drug Fusilev
Pharmaceutical company Sandoz Inc. was hit Friday with a patent infringement suit in Nevada federal court by oncology drug specialist Spectrum Pharmaceuticals Inc. and the University of Strathclyde, a Scottish institution, over plans to make a generic version of cancer drug Fusilev.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login